NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NLH - CA66980G1090 - Common Stock
0.28 CAD
-0.01 (-3.45%)
NLH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Providers & Services industry. NLH has an average financial health and profitability rating. NLH is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NLH had positive earnings in the past year.
In the past year NLH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
NLH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 3.18%, NLH belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
NLH's Return On Equity of 4.00% is fine compared to the rest of the industry. NLH outperforms 76.92% of its industry peers.
NLH has a Return On Invested Capital of 4.16%. This is in the better half of the industry: NLH outperforms 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROIC | 4.16% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NLH has a better Profit Margin (2.50%) than 76.92% of its industry peers.
NLH's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 3.56%, NLH is doing good in the industry, outperforming 61.54% of the companies in the same industry.
NLH's Gross Margin of 39.51% is in line compared to the rest of the industry. NLH outperforms 46.15% of its industry peers.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
Compared to 1 year ago, NLH has more shares outstanding
NLH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NLH has a worse debt to assets ratio.
2.2 Solvency
NLH has an Altman-Z score of 3.56. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.56, NLH belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
NLH has a debt to FCF ratio of 1.89. This is a very positive value and a sign of high solvency as it would only need 1.89 years to pay back of all of its debts.
NLH has a Debt to FCF ratio of 1.89. This is amongst the best in the industry. NLH outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, NLH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 3.56 |
ROIC/WACC0.53
WACC7.91%
2.3 Liquidity
A Current Ratio of 0.93 indicates that NLH may have some problems paying its short term obligations.
The Current ratio of NLH (0.93) is better than 84.62% of its industry peers.
NLH has a Quick Ratio of 0.93. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NLH (0.93) is better than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 260.00% over the past year.
Measured over the past years, NLH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.19% on average per year.
The Revenue has grown by 16.47% in the past year. This is quite good.
The Revenue has been growing by 8.16% on average over the past years. This is quite good.
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 28.00 indicates a quite expensive valuation of NLH.
Based on the Price/Earnings ratio, NLH is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of NLH to the average of the S&P500 Index (26.77), we can say NLH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | N/A |
4.2 Price Multiples
84.62% of the companies in the same industry are more expensive than NLH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.21 | ||
| EV/EBITDA | 10.42 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:NLH (12/30/2025, 7:00:00 PM)
0.28
-0.01 (-3.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap24.45M
Revenue(TTM)29.96M
Net Income(TTM)750.20K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | N/A | ||
| P/S | 0.6 | ||
| P/FCF | 11.21 | ||
| P/OCF | 11.04 | ||
| P/B | 0.95 | ||
| P/tB | 16.39 | ||
| EV/EBITDA | 10.42 |
EPS(TTM)0.01
EY3.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.92%
OCF(TTM)0.03
OCFY9.06%
SpS0.47
BVpS0.29
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROCE | 5.47% | ||
| ROIC | 4.16% | ||
| ROICexc | 4.52% | ||
| ROICexgc | 314.27% | ||
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% | ||
| FCFM | 5.32% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score7
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 5 | ||
| Cash Conversion | 87.34% | ||
| Profit Quality | 212.38% | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 3.56 |
F-Score7
WACC7.91%
ROIC/WACC0.53
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.32%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y15.07%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%
NOVA LEAP HEALTH CORP / NLH.CA FAQ
Can you provide the ChartMill fundamental rating for NOVA LEAP HEALTH CORP?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status for NLH stock?
ChartMill assigns a valuation rating of 3 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 5 / 10.
What is the financial health of NOVA LEAP HEALTH CORP (NLH.CA) stock?
The financial health rating of NOVA LEAP HEALTH CORP (NLH.CA) is 6 / 10.